Biomedical Engineering Reference
In-Depth Information
20. Potter L. K., Greller L. D., Cho C. R., Nuttall M. E., Stroup G. B., Suva L. J.,
Tobin F. L. Response to continuous and pulsatile PTH dosing: A mathematical
model for parathyroid hormone receptor kinetics. Bone 37 (2): 159-169 (2005).
21. Lemaire V., Tobin F. L., Greller L. D., Cho C. R., Suva L. J. Modeling the
interactions between osteoblast and osteoclast activities in bone remodeling.
Journal of Theoretical Biology 229 (3): 293-309 (2004).
22. Pivonka P., Zimak J., Smith D. W., Gardiner B. S., Dunstan C. R., Sims N. A.,
Martin T. J., Mundy G. R. Model structure and control of bone remodeling:
A theoretical study. Bone 43 (2): 249-263 (2008).
23. Kim C. H., Takai E., Zhou H., von Stechow D., Muller R., Dempster D. W.,
Guo X. E. Trabecular bone response to mechanical and parathyroid hormone
stimulation: the role of mechanical microenvironment. Journal of Bone Mineral
Research 18 (12): 2116-2125 (2003).
24. Whitfield J. F., Morley P., Willick G. E. Bone growth stimulators. New
tools for treating bone loss and mending fractures. Vitamins and Hormones
65: 1-80 (2002).
25. Wang J., Zhou J., Cheng C. M., Kopchick J. J., Bondy C. A. Evidence supporting
dual, IGF-I-independent and IGF-I-dependent, roles for GH in promoting
longitudinal bone growth. Journal of Endocrinology 180 (2): 247-255 (2004).
26. Donahue L. R., Rosen C. J. IGFs and bone: The osteoporosis connection revisited.
Proceedings of Society of Experimental Biology and Medicine 219: 1-7 (1998).
27. Goltzman D. Interactions of PTH and PTHrP with the PTH/PTHrP receptor
and with downstream signaling pathways: Exceptions that provide the rules.
Journal of Bone Mineral Research 14 (2): 173-177 (1999).
28. Teitelbaum S. L. Bone resorption by osteoclasts. Science 289  (5484):  1504-1508
(2000).
29. Aubin J. E., Bonnelye E. Osteoprotegerin and its ligand: A new paradigm for
regulation of osteoclastogenesis and bone resorption. Osteoporosis International
11 (11): 905-913 (2000).
30. Halladay D. L., Miles R. R., Thirunavukkarasu K., Chandrasekhar S., Martin
T. J., Onyia J. E. Identification of signal transduction pathways and promoter
sequences that mediate parathyroid hormone 1-38 inhibition of osteoprotegerin
gene expression. Journal of Cellular Biochemistry 84 (1): 1-11 (2002).
31. Isogai Y., Akatsu T., Ishizuya T., Yamaguchi A., Hori M., Takahashi N., Suda
T. Parathyroid hormone regulates osteoblast differentiation positively or
negatively depending on the differentiation stages. Journal of Bone Mineral
Research 11 (10): 1384-1393 (1996).
32. Zaidi M. Skeletal remodeling in health and disease. Nature Medicine
13 (7): 791-801 (2007).
33. Hofbauer L. C., Khosla S., Dunstan C. R., Lacey D. L., Boyle W. J., Riggs B. L. The
roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation
of bone resorption. Journal of Bone Mineral Research 15 (1): 2-12 (2000).
34. Tondravi M. M., McKercher S. R., Anderson K., Erdmann J. M., Quiroz M., Maki
R., Teitelbaum S. L. Osteopetrosis in mice lacking haematopoietic transcription
factor PU.1. Nature 386 (6620): 81-84 (1997).
35. Yoshida H., Hayashi S-I., Kunisada T., Ogawa M., Nishikawa S., Okamura H.,
Sudo T., Shultz L. D., Nishikawa S-I. The murine mutation osteopetrosis is in
the coding region of the macrophage colony stimulating factor gene. Nature
345 (6274): 442-444 (1990).
Search WWH ::




Custom Search